Ridgeback Biotherapeutics

FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19

This novel technology using green chemistry provides a sustainable, efficient and scalable form of treatment  to fight against COVID 19   New…

4 years ago